This article provides a 10-item checklist of cost-effective best practices for often-overlooked mid-life oncology products, five or so years after launch. Companies with growing oncology portfolios can use this list to determine not only if there’s hidden vitality left in their aging brands, but also to inspire outside-the-box, often low-investment, solutions to grow their bottom line.
